Breast Cancer Trial, Not Yet Recruiting (NCT07180433)

Breast Cancer Trial, Not Yet Recruiting NCT07180433 Sponsor: St. Olavs Hospital Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07180433 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

People who agree to undergo a type of specialised scan called an 18F-FAPI PET/MRI examination
People who have been diagnosed with breast cancer that has grown into nearby tissue (locally invasive breast cancer)
People who are scheduled to receive chemotherapy or other systemic treatment before surgery (called neoadjuvant therapy) as their main treatment
People who have breast cancer that has come back or is newly diagnosed
People who are scheduled to receive neoadjuvant therapy and have also had a different type of scan called an FDG-PET/CT as part of their staging (checking how far the cancer has spread)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

People who have a primary cancer other than breast cancer
People who have reduced kidney function or a known allergy to contrast agents (dyes used in scans)
People who have implants in their body that are not safe to use inside an MRI scanner

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07180433

Sponsor: St. Olavs Hospital

Phase: Not Applicable

Status: Not Yet Recruiting

Condition: Breast Cancer

More information: https://clinicaltrials.gov/study/NCT07180433

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who may be able to join

People who agree to undergo a type of specialised scan called an 18F-FAPI PET/MRI examination
People who have been diagnosed with breast cancer that has grown into nearby tissue (locally invasive breast cancer)
People who are scheduled to receive chemotherapy or other systemic treatment before surgery (called neoadjuvant therapy) as their main treatment
People who have breast cancer that has come back or is newly diagnosed
People who are scheduled to receive neoadjuvant therapy and have also had a different type of scan called an FDG-PET/CT as part of their staging (checking how far the cancer has spread)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

People who have a primary cancer other than breast cancer
People who have reduced kidney function or a known allergy to contrast agents (dyes used in scans)
People who have implants in their body that are not safe to use inside an MRI scanner

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Not Applicable

Sponsor

St. Olavs Hospital

Registry

ClinicalTrials.gov

Start date

1 October 2025

Est. completion

31 December 2028

Primary endpoints

Diagnostic accuracy of 18F-FAPI-PET/MRI in detection of breast cancer lesions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov

Who may and may not be able to join

Who may be able to join

Who may not be able to join

GP referral letter

Who may be able to join

Who may not be able to join

Trial details

Primary endpoints

Can't join this trial?

Expanded access pathways

Other trials for Breast Cancer